학술발표회 - 프로그램 리스트

123rd General Meeting of the KCS

52. Medicinal Chemistry Poster Presentation Medicinal Chemistry 발표일 : THU 발표형식 : Poster Presentation 현재 세션 총 발표 수 : 63편 발표코드 또는 제목을 클릭하시면 상세정보를 보실 수 있습니다. 표시가 있는 초록은 그림파일이 포함된 초록입니다.
No.	Room No.	Time	Code	Speaker	Affiliation	Subject	Chair
373	Exhibition Hall 2	포스터Ⅰ	MEDI.P-373	Juri Suh	Department of Chemistry, Korea University	Design, Synthesis, and Enzyme Inhibitory Activities against AXL and ACK1 of Novel Aminopyrimidine Derivatives
374	Exhibition Hall 2	포스터Ⅰ	MEDI.P-374	Sunwoo Lim	Department of Chemistry, Korea University	Identification of novel scaffold inhibitors of mammalian target of rapamycin (mTOR) from high-throughput screening
375	Exhibition Hall 2	포스터Ⅰ	MEDI.P-375	Sang Hyeob Lee	Department of Nanoscience, Nano Drug Delivery Lab	3D Printig feature evaluation of PCL/PEG/Gelatin composited scaffold for cell culture
376	Exhibition Hall 2	포스터Ⅰ	MEDI.P-376	Minji Kim	Department of Chemical & Biological Engineering, Hanbat National University	1H-indole-3-acetic acid (IAA) derivatives for Butrylcholinesterase Inhibitor
377	Exhibition Hall 2	포스터Ⅰ	MEDI.P-377	Sangwoo Kim	Department of Chemical & Biological Engineering, Hanbat National University	Identification and Biological Activities of taxifolin in Wolfiporia extensa
378	Exhibition Hall 2	포스터Ⅰ	MEDI.P-378	JaeHo Kim	Department of Chemistry, Korea University	Design, Synthesis and biological evaluation of novel pyrimidine derivatives as NUAK1 kinase inhibitors
379	Exhibition Hall 2	포스터Ⅰ	MEDI.P-379	Hanbyeol Park	Institute for New Drug Development, Division of Life Sciences	A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in a diabetic mouse model
380	Exhibition Hall 2	포스터Ⅰ	MEDI.P-380	Akshay Takwale	Medicinal chemistry and pharmacology, University of Science & Technology	Efficient and rapid synthesis of N-substituted isoquinolin-1(2H)-one under mild conditions: Facile access to doryamine derivatives
381	Exhibition Hall 2	포스터Ⅰ	MEDI.P-381	Jiwon Kim	medicinal chemistry and pharmacology, Korea Research Institute of Chemical Technology	EGFR exon 20 insertion mutations to NSCLC
382	Exhibition Hall 2	포스터Ⅰ	MEDI.P-382	AhRa Go	Center for Medicinal Chemistry, Korea Research Institute of Chemical Technology	Induced target degradation of BET by target degraducers(TDs)
383	Exhibition Hall 2	포스터Ⅰ	MEDI.P-383	Krishna babu Duggirala	University of Science & Technology	Discovery and Development of Allosteric Inhibitors of Kidney Type Glutaminase with high PK Properties and good Solubility.
384	Exhibition Hall 2	포스터Ⅰ	MEDI.P-384	Hyung Jun Ahn	Center for Theragnosis, Korea Institute of Science and Technology	Retargeting and antitumor effects of adeno-associated virus on OVCAR3 ovarian cancer in vivo
385	Exhibition Hall 2	포스터Ⅰ	MEDI.P-385	Yihoon Kim	Dept of Chemical & Molecular Eng/Applied Chemistry, Hanyang University	Development of NIR imaging probes for diagnosis of Alzheimer’s disease
386	Exhibition Hall 2	포스터Ⅰ	MEDI.P-386	Yanghwan Yun	Department of Chemistry, Keimyung University	2-Thioxothiazolidin-4-one derivatives as Pim kinase inhibitors
387	Exhibition Hall 2	포스터Ⅰ	MEDI.P-387	Si Yeon Han	Department of Chemistry, Dongguk University	Microwave-Assisted Facile Synthesis of 2,5-Piperazinedione Skeleton
388	Exhibition Hall 2	포스터Ⅰ	MEDI.P-388	Ye Ji Kim	Department of Chemistry, Dongguk University	Solid-Phase Synthesis of 2-Amino-5-Carboxamide Thiazole derivatives via Dehydrative Cyclization of Thiourea Intermediate Resin
389	Exhibition Hall 2	포스터Ⅰ	MEDI.P-389	Min jeong Cha	Department of Chemistry, Dongguk University	Solid-Phase Parallel Synthesis of 1,3-thiazole Derivatives Based on Peptidomimetics
390	Exhibition Hall 2	포스터Ⅰ	MEDI.P-390	Hyejin Kwon	Department of Chemistry, Dongguk University	Design and Solid-Phase Parallel Synthesis of 2,4,5-Trisubstituted Thiazole Derivatives via Cyclization Reaction with a Carbamimidothioate Linker
391	Exhibition Hall 2	포스터Ⅰ	MEDI.P-391	Hyung Jun Ahn	Center for Theragnosis, Korea Institute of Science and Technology	PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery carrier for ovarian cancer therapy
392	Exhibition Hall 2	포스터Ⅰ	MEDI.P-392	Haeun Lee	University of Science and Technology	Tau-Targeted Drug Discovery for the Treatment of Alzheimer’s Disease
393	Exhibition Hall 2	포스터Ⅰ	MEDI.P-393	Jee yun Ahn	Department of Biotechnology, Yonsei University	Development of Potent β-Arrestin-biased S1P₁ Agonist for Treatment of Multiple Sclerosis
394	Exhibition Hall 2	포스터Ⅰ	MEDI.P-394	Sung Eon Jin	Department of Chemistry, Ulsan National Institute of Science and Technology	Location of peptide assembly determines the death mechanism
395	Exhibition Hall 2	포스터Ⅰ	MEDI.P-395	Youjung Sim	Department of Chemistry, Ulsan National Institute of Science and Technology	~~Catalase Conjugated Metal-Organic-Framework for Effective Photodynamic Therapy by Relieving Tumor Hypoxia~~
396	Exhibition Hall 2	포스터Ⅰ	MEDI.P-396	Hyeon Ji Kim	Convergence Research Center for Dementia, Korea Institute of Science and Technology	Synthesis and Evaluation of Novel Functionalized Amino Acid Derivatives for Treatment of Cryptococcal Meningitis
397	Exhibition Hall 2	포스터Ⅰ	MEDI.P-397	Jong Seok Yoo	Convergence Research Center for Dementia, Korea Institute of Science and Technology	Development and Optimization of Halogenated Vinyl Sulfones as Nrf2 Activators for the Treatment of Parkinson’s Disease
398	Exhibition Hall 2	포스터Ⅰ	MEDI.P-398	Hye Yeon Lee	Department of Chemistry, Korea University	Development of Novel Tau Aggregation Inhibitors for the Treatment of Alzheimer's Disease
399	Exhibition Hall 2	포스터Ⅰ	MEDI.P-399	Jina Kim	New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation	Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor‑γ Inverse Agonists
400	Exhibition Hall 2	포스터Ⅰ	MEDI.P-400	Sun Jun Park	Convergence Research Center for DTC, Korea Institute of Science and Technology	Development of Novel biased agonists against S1P1 receptor for Treatment of Multiple Sclerosis
401	Exhibition Hall 2	포스터Ⅰ	MEDI.P-401	WooSeung Son	Department of Chemistry, Yonsei University	Novel tau aggregation inhibitors for treatment of Alzheimer’s Disease
402	Exhibition Hall 2	포스터Ⅰ	MEDI.P-402	Boko Jang	Convergence Research Center for DTC, Korea Institute of Science and Technology	A Novel Chalcone Derivative Suppress Inflammation via Nrf2 Activation and Attenuates the Learning and Memory Impairment in Scopolamine-Induced Mouse Model
403	Exhibition Hall 2	포스터Ⅰ	MEDI.P-403	Siwon Kim	Convergence Research Center for DTC, Korea Institute of Science and Technology	Neuroprotective Effects of Nrf2 Activator via Inhibition of Protein-protein Interaction in a Mouse Model of Parkinson’s Disease
404	Exhibition Hall 2	포스터Ⅰ	MEDI.P-404	Ji Won Choi	Convergence Research Center for Dementia, Korea Institute of Science and Technology	Design, Synthesis and Optimization of Novel Class of Nrf2 Activator as a Neuroprotective Agent for Treatment of Parkinson’s disease
405	Exhibition Hall 2	포스터Ⅰ	MEDI.P-405	Seokjun Jo	Chungbuk Natioanl University	Niclosamide derivatives inhibit CIP2A and reactivate tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
406	Exhibition Hall 2	포스터Ⅰ	MEDI.P-406	Eunyeong Rim	Department of Medicinal Chemistry & Pharmacology, University of Science & Technology	Design, synthesis and biological evaluation of phenoxazine derivatives as clathrin inhibitors
407	Exhibition Hall 2	포스터Ⅰ	MEDI.P-407	Jong-Hyun Park	Convergence Research Center for Dementia, Korea Institute of Science and Technology	Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease
408	Exhibition Hall 2	포스터Ⅰ	MEDI.P-408	Tara Man Kadayat	New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation	A Retro-biosynthetic Accelerated Approach to Finding Novel Synthetic Scaffolds of Hit to Lead Compounds
409	Exhibition Hall 2	포스터Ⅰ	MEDI.P-409	Heeyoung Lee	School of Pharmacy, Sungkyunkwan University	Diastereoselective Synthesis of 1-Aminoindanes via Rhodium(III) Catalyzed C-H Activation
410	Exhibition Hall 2	포스터Ⅰ	MEDI.P-410	Neeraj kumar Mishra	School of Pharmacy, Sungkyunkwan University	The reactivity of MBH adducts with benzylamines to access the 2-benzazepines under Rh(III) catalysis
411	Exhibition Hall 2	포스터Ⅰ	MEDI.P-411	Taejung Kim	Natural Products Research, Korea Institute of Science and Technology	Ginsenoside Rb2 suppresses the glutamate-mediated oxidative stress and neuronal cell death in HT22 cells
412	Exhibition Hall 2	포스터Ⅰ	MEDI.P-412	Taejoo Jeong	School of Pharmacy, Sungkyunkwan University	C-H Aminocarbonylation of N-(Hetero)aryl-7-azaindoles with Isocyanate under Ruthenium(II) Catalysis
413	Exhibition Hall 2	포스터Ⅰ	MEDI.P-413	Young seok Kim	Gangneung-Wonju National University	Synthesis, Structure Revision, and Biological Evaluation of Nocarbenzoxazoles
414	Exhibition Hall 2	포스터Ⅰ	MEDI.P-414	Taejung Kim	Natural Products Research, Korea Institute of Science and Technology	Total Synthesis of Pactalactam, a Cyclic Urea Analog of Pactamycin
415	Exhibition Hall 2	포스터Ⅰ	MEDI.P-415	Ye Ri Han	New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation	Discovery of Imidazopyridine Derivatives as Type II Inhibitors of the T315I Mutant BCR-ABL-Target
416	Exhibition Hall 2	포스터Ⅰ	MEDI.P-416	Bong Geun Song	Department of Chemistry, Gangneung-Wonju National University	The change of ginsenosides composition in ginseng leaves extract by the microwave-processed
417	Exhibition Hall 2	포스터Ⅰ	MEDI.P-417	Hyung Soo Kim	organic chemistry, Korea University	A novel cereblon modulator for targeted protein degradation
418	Exhibition Hall 2	포스터Ⅰ	MEDI.P-418	Tara Man Kadayat	New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation	Synthesis and recent updates on thiazoline containing agonists of selective peroxisome proliferator-activated receptor δ
419	Exhibition Hall 2	포스터Ⅰ	MEDI.P-419	Eun Bi Ko	New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation	The Development and lead Optimization of Transglutaminase 2 Inhibitors for the Treatment of Renal Cell Carcinoma (RCC).
420	Exhibition Hall 2	포스터Ⅰ	MEDI.P-420	Jusuk Lee	New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation	Pyrrolo[2,3-D] Pyrimidine derivatives, A Cathepsin K Inhibitor for The Treatment of Osteoporosis
421	Exhibition Hall 2	포스터Ⅰ	MEDI.P-421	Seon-Jun Choi	Natural Products Research, Korea Institute of Science and Technology	Studies of secondary metabolites isolated from Korean mushroom
422	Exhibition Hall 2	포스터Ⅰ	MEDI.P-422	Eunhye Lee	New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF)	Development and Lead optimization of CETP inhibitors for cardiovascular diseases
[First 1][1] [2] [Last 2]

52. Medicinal Chemistry Poster Presentation